Synthesis, anticancer evaluation, CDK2 inhibition, and apoptotic activity assessment with molecular docking modeling of new class of pyrazolo[1,5-a]pyrimidines
Crossref DOI link: https://doi.org/10.1007/s11164-021-04564-x
Published Online: 2021-08-29
Published Print: 2021-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Metwally, Nadia Hanafy
Mohamed, Mona Said
Deeb, Emad Abdullah
Text and Data Mining valid from 2021-08-29
Version of Record valid from 2021-08-29
Article History
Received: 9 April 2021
Accepted: 3 August 2021
First Online: 29 August 2021